Our study has determined that the assessment of NGAL plasma levels among patients undergoing scheduled angiography should increase after the administration of a contrast agent, with good diagnostic power for the differentiation of both clinical and subclinical forms of CI-AKI. The gene discussed is LCN2; the disease is acute kidney injury.